Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.
暂无分享,去创建一个
Ji Guo | Stephanie E. A. Gratton | Joseph M Desimone | J. DeSimone | P. Pohlhaus | Jin Lee | Ji Guo | M. Cho | Moo J Cho | Jin Lee | Stephanie E A Gratton | Patrick D Pohlhaus | S. Gratton | J. Desimone
[1] D. Crommelin,et al. The effect of aging on the physical stability of liposome dispersions. , 1992, Chemistry and physics of lipids.
[2] Yale N. Patt,et al. One Billion Transistors, One Uniprocessor, One Chip , 1997, Computer.
[3] J H Senior,et al. Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.
[4] María J Vicent,et al. Polymer conjugates: nanosized medicines for treating cancer. , 2006, Trends in biotechnology.
[5] R. Samulski,et al. Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agents. , 2002, Journal of the American Chemical Society.
[6] M. Hashida,et al. Macromolecular Carrier Systems for Targeted Drug Delivery: Pharmacokinetic Considerations on Biodistribution , 1996, Pharmaceutical Research.
[7] Francis C Szoka,et al. Designing dendrimers for biological applications , 2005, Nature Biotechnology.
[8] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[9] J. G. Cory,et al. 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicators , 1991 .
[10] T. Allen,et al. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.
[11] Ginger M. Denison,et al. High-resolution soft lithography: enabling materials for nanotechnologies. , 2004, Angewandte Chemie.
[12] A. C. Hunter,et al. Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] M. Woodle,et al. Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.
[14] V. Torchilin. Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.
[15] Kazunori Kataoka,et al. Block copolymer micelles as long-circulating drug vehicles , 1995 .
[16] Joseph M DeSimone,et al. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.
[17] Stephanie E. A. Gratton,et al. Imparting size, shape, and composition control of materials for nanomedicine. , 2006, Chemical Society reviews.
[18] V. Torchilin,et al. Targeted polymeric micelles for delivery of poorly soluble drugs , 2004, Cellular and Molecular Life Sciences CMLS.
[19] T. Baker,et al. Adding the Third Dimension to Virus Life Cycles: Three-Dimensional Reconstruction of Icosahedral Viruses from Cryo-Electron Micrographs , 2000, Microbiology and Molecular Biology Reviews.
[20] E. Henze,et al. Iodine-123 labelling of atrial natriuretic peptide and its analogues: initial results , 1993, European Journal of Nuclear Medicine.
[21] F. Szoka,et al. Acid-triggered transformation of diortho ester phosphocholine liposome. , 2006, Journal of the American Chemical Society.
[22] P. Cullis,et al. β2-Glycoprotein I Is a Major Protein Associated with Very Rapidly Cleared Liposomes in Vivo, Suggesting a Significant Role in the Immune Clearance of "Non-self" Particles (*) , 1995, The Journal of Biological Chemistry.
[23] R. Duncan. The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.
[24] Theresa M. Allen,et al. Pharmacokinetics of long-circulating liposomes , 1995 .
[25] D. Papahadjopoulos,et al. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.
[26] Papisov. Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions. , 1998, Advanced drug delivery reviews.
[27] T. Okano,et al. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[28] G Gregoriadis,et al. Engineering liposomes for drug delivery: progress and problems. , 1995, Trends in biotechnology.
[29] Yechezkel Barenholz,et al. Liposome application: problems and prospects , 2001 .
[30] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.